表紙
市場調查報告書
商品編碼
1022593

一次性使用生物製程的全球市場 (∼2026年):各產品 (培養袋&容器、生物反應器、攪拌機、集合)、用途 (細胞培養、混合、保管、過濾、精製)、終端用戶 (生物醫藥品企業、CRO、CMO)、地區

Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User (Biopharma Companies, CROs, CMOs) - Global Forecast 2026

出版日期: | 出版商: MarketsandMarkets | 英文 200 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

一次性使用生物製程的市場規模在預測期間內預計以20.5%的年複合成長率發展,從2021年的82億美元,成長到2026年208億美元的規模。

各產品中,一次性使用培養袋&容器的部門2020年顯示最大的佔有率,在預測期間中顯示最大的成長率。還有各用途,過濾的部門顯示最大的佔有率。

本報告提供全球一次性使用生物製程的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,技術橫行,價格趨勢,市場規模的變化、預測,產品、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
  • 價值鏈分析
  • 價格分析
  • 技術分析
  • COVID-19的影響

第6章 市場分析、預測:各產品

  • 一次性使用培養袋、容器
  • 一次性使用集合
  • 一次性使用生物反應器
  • 一次性使用攪拌機
  • 其他

第7章 市場分析、預測:各用途

  • 過濾
  • 保管
  • 細胞培養
  • 混合
  • 精製

第8章 市場分析、預測:各終端用戶

  • 生物醫藥品、製藥企業
  • CRO、CMO
  • 學術機構、研究機關

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 市場評估架構
  • 企業評估象限
  • 市場排名分析
  • 競爭模式

第11章 企業簡介

  • SARTORIUS STEDIM BIOTECH
  • DANAHER CORPORATION
  • THERMO FISHER SCIENTIFIC
  • MERCK KGAA
  • GETINGE AB
  • EPPENDORF AG
  • CORNING
  • ENTEGRIS
  • AVANTOR
  • CESCO BIOENGINEERING CO., LTD.
  • CELLEXUS
  • PBS BIOTECH, INC.
  • DISTEK, INC.
  • ABEC, INC.
  • ABLE CORPORATION & BIOTT CORPORATION
  • G&G TECHNOLOGIES, INC.
  • SOLIDA BIOTECH GMBH
  • SATAKE CHEMICAL EQUIPMENT MFG., LTD.
  • STOBBE PHARMA GMBH
  • CELLTAINER BIOTECH BV
  • MEISSNER FILTRATION PRODUCTS, INC.
  • BBI-BIOTECH
  • PIERRE GUERIN
  • KUHNER AG
  • OMNIBRX BIOTECHNOLOGIES

第12章 附錄

目錄
Product Code: BT 4630

The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. Single-use bioprocessing is a rapidly evolving technology used to develop disposable bioprocessing equipment and accessories to manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind using single-use bioprocessing technology in the bioprocess is to decrease the cost associated with complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.

"The single-use media bags and containerssegment accounted for the highest growth rate in the single use bioprocessingmarket, byproduct, during the forecast period"

In 2020, the single-use media bags and containers segment accounted for the largest shareof the single use bioprocessing market, mainly because they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.

"Filtrationsegment accounted for the largest share of the application segment"

In 2020, the filtration application accounted for the largest share.A single-use capsule filter, for instance, serves as an effective substitute for stainless steel housings that require the installation of filter elements. Considering that a fully integrated, single-use system, including the filter, bag, tubing, and other components, is manufactured and sterilized as one eliminates the contamination risks associated with aseptic connections during coupling. Single-use filtration systems also ensure that operators do not come in contact with cleaning solutions, cytotoxic fluids, or buffers with extreme pH.The single-use nature of this type of filtration system eliminates the need for system maintenance, cleaning and cleaning validation and avoids any possibility of contamination from product to product or batch to batch.

"Asia Pacific: The fastest-growing regionin thesingle use bioprocessingmarket"

Thesingle use bioprocessing market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). Significant investments by key market players, increasing government support, and developing R&D infrastructure are the major factors fueling the growth of the singleuse bioprocessing market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80%and Demand Side 20%
  • By Designation: C-level - 25%, D-level - 20%, and Others - 55%
  • By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:

  • Sartorius Stedim Biotech S. A. (France)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • Getinge AB (Sweden)
  • Eppendorf AG (Germany)
  • Corning (US)
  • Entegris (US)
  • Avantor (US)
  • CESCO Bioengineering Co. Ltd. (Taiwan)
  • Cellexus (UK)
  • PBS Biotech, Inc. (US)
  • Distek, Inc. (US)
  • ABEC, Inc. (US)
  • Able Corporation &Biott Corporation (Japan)
  • G&G Technologies (US)
  • Solida Biotech GmbH (Germany)
  • Satake Chemical Equipment Mfg., Ltd. (Japan)
  • Stobbe Pharma GmbH (Switzerland)
  • Celltainer Biotech (Netherlands)
  • Meissner Filtration roducts, Inc. (US)
  • bbi-biotech GmbH (Germany)
  • Pierre Guerin (France)
  • Kuhner AG (Switzerland)
  • OmniBRx Biotechnologies (India).

Research Coverage:

This report provides a detailed picture of thesingle use bioprocessing market. It aims at estimating the size and future growth potential of the market across different segments such as theproduct, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall singleuse bioprocessing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH METHODOLOGY
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY SOURCES: SINGLE-USE BIOPROCESSING MARKET
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 2 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
    • FIGURE 3 SINGLE-USE BIOPROCESSING MARKET: FINAL MARKET (USD BILLION)
    • FIGURE 4 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOPROCESSING MARKET
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
    • 2.3.1 KEY INDUSTRY INSIGHTS
    • 2.3.2 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 MEDIA BAGS AND CONTAINERS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
    • FIGURE 7 FILTRATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET DURING THE FORECAST PERIOD
    • FIGURE 8 CROS AND CMOS TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET DURING THE FORECAST PERIOD
    • FIGURE 9 GEOGRAPHICAL SNAPSHOT: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET IN 2020

4 PREMIUM INSIGHTS

  • 4.1 SINGLE-USE BIOPROCESSING MARKET OVERVIEW, 2021 VS. 2026
    • FIGURE 10 RISING DEMAND FOR BIOPHARMACEUTICALS IS A KEY DRIVER FOR MARKET GROWTH
  • 4.2 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT & COUNTRY (2021)
    • FIGURE 11 MEDIA BAGS AND CONTAINERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
  • 4.3 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
    • FIGURE 12 THE FILTRATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET IN 2020
  • 4.4 SINGLE-USE BIOPROCESSING MARKET, BY END USER
    • FIGURE 13 BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE END USERS SEGMENT IN 2020

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 14 SINGLE-USE BIOPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 DRIVERS
      • 5.1.1.1 The growing demand for biopharmaceuticals
      • 5.1.1.2 Reduced investments for single-use bioprocessing technologies
    • FIGURE 15 IMPACT ON VARIOUS PARAMETERS: SINGLE-USE SYSTEMS VS. STAINLESS STEEL SYSTEMS
      • 5.1.1.3 Faster implementation and lower risk of product cross-contamination
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 Issues related to leachables and extractables
    • TABLE 1 KEY EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Emerging markets
      • 5.1.3.2 Patent Expiry
    • FIGURE 16 US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Waste disposal
    • TABLE 2 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
      • 5.1.4.2 Issues associated with scalability
  • 5.2 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 17 PORTER'S FIVE FORCES ANALYSIS (2020)
    • 5.2.1 THREAT FROM NEW ENTRANTS
    • 5.2.2 THREAT FROM SUBSTITUTES
    • 5.2.3 BARGAINING POWER OF SUPPLIERS
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 18 VALUE CHAIN ANALYSIS OF THE ECOSYSTEM OF SINGLE-USE BIOPROCESSING: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
  • 5.4 PRICING ANALYSIS
    • TABLE 3 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS BY REGION (2019)
  • 5.5 TECHNOLOGICAL ANALYSIS
  • 5.6 IMPACT OF COVID-19 OUTBREAK ON THE SINGLE-USE BIOPROCESSING MARKET

6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 5 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
  • 6.2 SINGLE-USE MEDIA BAGS AND CONTAINERS
    • 6.2.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESSING OPERATIONS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
    • TABLE 6 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 7 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 8 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 9 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 10 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 11 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 12 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 13 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.3 SINGLE-USE ASSEMBLIES
    • 6.3.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE ASSEMBLIES
    • TABLE 14 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 15 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 16 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 17 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 18 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 19 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.4 SINGLE-USE BIOREACTORS
    • 6.4.1 SINGLE-USE BIOREACTOR SYSTEMS OFFER GREAT FLEXIBILITY OF OPERATIONS
    • TABLE 22 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 23 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 25 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 26 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 27 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 28 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.5 DISPOSABLE MIXERS
    • 6.5.1 DISPOSABLE MIXERS OFFER REDUCED RISK OF CROSS CONTAMINATION WHICH DRIVES THE GROWTH OF THIS SEGMENT
    • TABLE 30 DISPOSABLE MIXERS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 31 DISPOSABLE MIXERS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 32 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 33 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 34 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 35 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.6 OTHER PRODUCTS
    • TABLE 38 OTHER PRODUCTS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 40 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 41 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 42 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 43 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 44 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 46 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 47 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
  • 7.2 FILTRATION
    • TABLE 48 FILTRATION APPLICATION, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 49 FILTRATION APPLICATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 51 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 52 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 53 EUROPE: FILTRATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.3 STORAGE
    • 7.3.1 SINGLE-USE STORAGE SYSTEMS OFFER COST SAVINGS ON STERILIZATION PROCESS
    • TABLE 56 STORAGE APPLICATION, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 57 STORAGE APPLICATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 58 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 59 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 60 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 61 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.4 CELL CULTURE
    • 7.4.1 SINGLE-USE CELL CULTURE PRODUCTS OFFER REDUCED RISK OF CONTAMINATION
    • TABLE 64 CELL CULTURE APPLICATION, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 65 CELL CULTURE APPLICATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 66 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 67 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 68 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 69 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.5 MIXING
    • 7.5.1 DISPOSABLE MIXING SYSTEMS ARE COST-EFFICIENT, PREVENTING CLEANING AND STERILIZATION CHARGES
    • TABLE 72 MIXING APPLICATION, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 73 MIXING APPLICATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 75 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 76 EUROPE: MIXING APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 77 EUROPE: MIXING APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.6 PURIFICATION
    • 7.6.1 SINGLE-USE PURIFICATION PRODUCTS ARE INCREASINGLY IN DEMAND OWING TO FLEXIBILITY OF USE
    • TABLE 80 PURIFICATION APPLICATION, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 81 PURIFICATION APPLICATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 82 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 83 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 84 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 85 EUROPE: PURIFICATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY, 2021-2026 (USD MILLION)

8 SINGLE-USE BIOPROCESSING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 88 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 89 SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 8.2 BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES
    • 8.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOPROCESSING EQUIPMENT IN THIS END-USER SEGMENT
    • TABLE 90 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 91 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 92 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 93 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 94 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 95 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
    • 8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF CROS AND CMOS
    • TABLE 98 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 99 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 100 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 101 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 102 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 103 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE THE MARKET GROWTH
    • TABLE 106 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 107 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 108 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 109 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 110 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 111 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)

9 SINGLE-USE BIOPROCESSING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 114 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 115 SINGLE-USE BIOPROCESSING MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
    • TABLE 116 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 117 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 118 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 119 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 120 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The growing focus on biopharmaceutical production in the US drives the market growth
    • TABLE 124 US: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 The increasing incidences of lifestyle diseases such as cancer drive the market growth for biologics in Canada
    • TABLE 130 CANADA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 136 EUROPE: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing adoption of single-use bioprocessing equipment by biopharma and CDMO companies to drive the market growth
    • TABLE 144 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 145 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 146 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 147 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 148 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 149 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies in the UK
    • TABLE 150 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 151 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 152 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 153 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 154 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 155 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing investments in life sciences R&D infrastructure development to drive the market growth in France
    • TABLE 156 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 157 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 158 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 159 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 160 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 161 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.4 REST OF EUROPE (ROE)
    • TABLE 162 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 163 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 164 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 165 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 166 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 167 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • TABLE 168 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • FIGURE 21 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT
    • 9.4.1 CHINA
      • 9.4.1.1 Government support and significant private investments to drive the market growth in China
    • TABLE 176 CHINA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Increasing biomanufacturing investments to favor the market growth
    • TABLE 182 JAPAN: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Low manufacturing and labor costs make India a lucrative country for single-use bioprocessing equipment manufacturers
    • TABLE 188 INDIA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 194 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 195 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 196 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 197 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 198 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 199 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.5 LATIN AMERICA (LATAM)
    • 9.5.1 BRAZIL ACCOUNTS FOR THE LARGEST SHARE OF THE LATAM REGION FOR SINGLE-USE BIOPROCESSING IN 2020
    • TABLE 200 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 201 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 202 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 203 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 204 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 205 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA (MEA)
    • 9.6.1 THE GROWTH OF THE BIOTECHNOLOGY INDUSTRY IN THIS REGION DRIVES THE WIDE ADOPTION OF SINGLE-USE BIOPROCESSING PRODUCTS
    • TABLE 206 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 207 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2021-2026 (USD MILLION)
    • TABLE 208 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 209 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 210 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 211 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2021-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 MARKET EVALUATION FRAMEWORK
  • 10.2 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION QUADRANT
    • 10.2.1 STARS
    • 10.2.2 EMERGING LEADERS
    • 10.2.3 PERVASIVE
    • 10.2.4 PARTICIPANTS
    • FIGURE 22 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION MATRIX, 2020
  • 10.3 MARKET RANK ANALYSIS
    • FIGURE 23 SINGLE-USE BIOPROCESSING MARKET: MARKET RANKING OF KEY PLAYERS (2020)
  • 10.4 COMPETITIVE SCENARIO
    • 10.4.1 KEY PRODUCT LAUNCHES
    • 10.4.2 KEY ACQUISITIONS
    • 10.4.3 KEY PARTNERSHIPS AND AGREEMENTS
    • 10.4.4 KEY EXPANSIONS

11 COMPANY PROFILES

  • (Business overview, Products offered, Recent Developments,SWOT Analysis, MNM view)**
  • 11.1 SARTORIUS STEDIM BIOTECH
    • TABLE 212 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
    • FIGURE 24 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
  • 11.2 DANAHER CORPORATION
    • TABLE 213 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
  • 11.3 THERMO FISHER SCIENTIFIC
    • TABLE 214 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
  • 11.4 MERCK KGAA
    • TABLE 215 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2020)
  • 11.5 GETINGE AB
    • TABLE 216 GETINGE AB: BUSINESS OVERVIEW
    • FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2020)
  • 11.6 EPPENDORF AG
    • TABLE 217 EPPENDORF AG: BUSINESS OVERVIEW
    • FIGURE 29 EPPENDORF: COMPANY SNAPSHOT (2020)
  • 11.7 CORNING
    • TABLE 218 CORNING: BUSINESS OVERVIEW
    • FIGURE 30 CORNING COMPANY SNAPSHOT (2020)
  • 11.8 ENTEGRIS
    • TABLE 219 ENTEGRIS: BUSINESS OVERVIEW
    • FIGURE 31 ENTEGRIS COMPANY SNAPSHOT (2020)
  • 11.9 AVANTOR
    • TABLE 220 AVANTOR: BUSINESS OVERVIEW
    • FIGURE 32 AVANTOR: COMPANY SNAPSHOT (2020)
  • 11.10 CESCO BIOENGINEERING CO., LTD.
    • TABLE 221 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
  • 11.11 CELLEXUS
    • TABLE 222 CELLEXUS: BUSINESS OVERVIEW
  • 11.12 PBS BIOTECH, INC.
    • TABLE 223 PBS BIOTECH, INC.: BUSINESS OVERVIEW
  • 11.13 DISTEK, INC.
    • TABLE 224 DISTEK, INC.: BUSINESS OVERVIEW
  • 11.14 ABEC, INC.
    • TABLE 225 ABEC INC.: BUSINESS OVERVIEW
  • 11.15 ABLE CORPORATION & BIOTT CORPORATION
    • TABLE 226 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW
  • 11.16 G&G TECHNOLOGIES, INC.
    • TABLE 227 G&G TECHNOLOGIES INC.: BUSINESS OVERVIEW
  • 11.17 SOLIDA BIOTECH GMBH
    • TABLE 228 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
  • 11.18 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
    • TABLE 229 SATAKE CHEMICAL EQUIPMENT MFG. LTD: BUSINESS OVERVIEW
  • 11.19 STOBBE PHARMA GMBH
    • TABLE 230 STOBBE PHARMA GMBH: BUSINESS OVERVIEW
  • 11.20 CELLTAINER BIOTECH BV
    • TABLE 231 CELLTAINER BIOTECH BV: BUSINESS OVERVIEW
  • 11.21 MEISSNER FILTRATION PRODUCTS, INC.
    • TABLE 232 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW
  • 11.22 BBI-BIOTECH
    • TABLE 233 BBI BIOTECH: BUSINESS OVERVIEW
  • 11.23 PIERRE GUERIN
    • TABLE 234 PIERRE GUERIN: BUSINESS OVERVIEW
  • 11.24 KUHNER AG
    • TABLE 235 KUHNER AG: BUSINESS OVERVIEW
  • 11.25 OMNIBRX BIOTECHNOLOGIES
  • *Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS